Trichrysis baratzsensis sp. nov. (Hymenoptera: Chrysididae) from Sardinia

Trichrysis baratzsensis sp. nov., from Lago Baratz (Sassari province, Sardinia), is described and compared with all other Palaearctic congeners. A key for the identification of Mediterranean Trichrysis species is also provided

RESEARCH ON THE SUBFAMILY CHRYSIDINAE (HYMENOPTERA: CHRYSIDIDAE) FAUNA OF TURKEY WITH DISTRIBUTIONAL EVALUATION

The present study is based on chrysidid samples in the subfamily Chrysidinae collected from various parts of Turkey since the 1970s. A total of 90 species and subspecies are recognized in seven genera: Chrysidea (1), Chrysis (70), Chrysura (13), Pseudochrysis (2), Spinolia (2), Spintharina (1), and Euchroeus (1). Of these, Chrysis verae Semenov 1967 is new for the Turkish fauna. Moreover, Chrysis cingulicornis Förster 1853, Ch. cylindrica Eversmann 1857,  Ch. decora Mocsáry 1889, Ch. lepida Mocsáry1889, Ch. marani centropunctata Linsenmaier 1968, Ch. viridissima fasciolata Klug 1845, Chrysura barbatula Linsenmaier 1968, and Pseudospinolia neglectoides (Linsenmaier 1959) are recorded for the first time in the eastern Anatolian region. Those of Chrysis confluens (Dahlbom 1845) and Euchroeus purpuratus consularis Buysson 1896 are recorded from central and eastern Anatolia, Chrysis bytinskii Linsenmaier 1959 from the Mediterranean region, Chrysis krueperi Mocsáry 1897 from the Marmara region,          Ch. marginata Mocsáry 1889 from central Anatolia and Mediterranean regions, Ch. lateralis Dahlbom, 1845 from central Anatolia, Chrysura varicornis (Spinola 1838) from the southeastern Anatolian region. New distributional data of most of the taxa are evaluated. The species show different distribution patterns; most of them have been rarely recorded, the rest of them are moderately and frequently recorded. Certain species are recorded from one or two provinces, even with a single sample. For instance, Chrysis aeraria (Mocsáry, 1914), Ch. jucunda Mocsáry, 1889 and Ch. viridissima fasciolata Klug, 1845 are known from one province each. They could be classified as endangered species and should be added to the IUCN red list

Definitive childlessness in women with multiple sclerosis: a multicenter study

The frequency of definitive childlessness in women with multiple sclerosis (MS) may be higher than in the general population. MS may also affect decisions on the delivery procedure and on breast-feeding issues. Aim of the study was to assess the frequency of childlessness and its possible causes, the proportion of cesarean deliveries (CD), and the frequency of breast-feeding in patients and controls who have reached the end of their reproductive period. Female MS patients (>43 years) and controls (>45 years) filled out a questionnaire. We enrolled 303 patients and 500 controls. MS was associated with a higher frequency of childlessness (22 vs 13%) and less patients were in a stable relationship (83 vs 89%). There was no difference in the reported rates of infertility and miscarriages, while elective abortions were more frequent in patients (20 vs 12%). MS did not significantly affect the frequency of CD or of breast-feeding. MS-related reasons for childlessness, reported by 16% of childless patients, included disability/fear of future disability, fear of genetically transmitting MS, fear of not starting/discontinuing treatments, and discouragement by physician. Definitive childlessness is more frequent in women with MS compared to controls. A portion of voluntary childlessness may be avoided through correct/tailored information to patients

Comisión de Innovación, Transferencia y Vinculación Tecnológica Informe 1

Primera dimensión de análisis transversal: Integración interna (intrainstitucional)Fil: Arias, Fulvio. Universidad Nacional de Córdoba. Facultad de Ciencias Exactas, Físicas y Naturales; Argentina.Fil: Berti, Agustín. Universidad Nacional de Córdoba. Facultad de Artes; Argentina.Fil: Colombo, Andrés. Universidad Nacional de Córdoba. Secretaría de Ciencia y Tecnología; Argentina.Fil: Dalmagro, María Cristina. Universidad Nacional de Córdoba. Facultad de Lenguas; Argentina.Fil: Francisca, Franco Matías. Universidad Nacional de Córdoba. Secretaría de Ciencia y Tecnología; Argentina.Fil: Giacomelli, Carla. Universidad Nacional de Córdoba. Secretaría de Ciencia y Tecnología; Argentina.Fil: Guzmán, Patricia Elizabeth. Universidad Nacional de Córdoba. Secretaría de Ciencia y Tecnología; Argentina.Fil: Matta, Andrés. Universidad Nacional de Córdoba. Facultad de Ciencias Económicas; Argentina.Fil: Pury, Pedro Ángel. Universidad Nacional de Córdoba. Facultad de Matemática, Astronomía, Física y Computación; Argentina.Fil: Ruiz Caturelli, Miguel. Universidad Nacional de Córdoba. Facultad de Ciencias Exactas, Físicas y Naturales; Argentina.Fil: Strumia, Miriam. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas; Argentina

Comisión de Innovación, Transferencia y Vinculación Tecnológica Acta 5

El coordinador de la subcomisión hace una revisión de la dimensión 2, la integración con el medio (interinstitucional), y de la puesta en común en la reunión anterior sobre las instituciones, organizaciones, órganos de gobierno y los principales sectores externos a la UNC con los cuales existen, podrían o deberían existir relaciones institucionales.Fil: Arias, Fulvio. Universidad Nacional de Córdoba. Facultad de Ciencias Exactas, Físicas y Naturales; Argentina.Fil: Berti, Agustín. Universidad Nacional de Córdoba. Facultad de Artes; Argentina.Fil: Colombo, Andrés. Universidad Nacional de Córdoba. Secretaría de Ciencia y Tecnología; Argentina.Fil: Dalmagro, María Cristina. Universidad Nacional de Córdoba. Facultad de Lenguas; Argentina.Fil: Francisca, Franco Matías. Universidad Nacional de Córdoba. Secretaría de Ciencia y Tecnología; Argentina.Fil: Giacomelli, Carla. Universidad Nacional de Córdoba. Secretaría de Ciencia y Tecnología; Argentina.Fil: Guzmán, Patricia Elizabeth. Universidad Nacional de Córdoba. Secretaría de Ciencia y Tecnología; Argentina.Fil: Matta, Andrés. Universidad Nacional de Córdoba. Facultad de Ciencias Económicas; Argentina.Fil: Pury, Pedro Ángel. Universidad Nacional de Córdoba. Facultad de Matemática, Astronomía, Física y Computación; Argentina.Fil: Ruiz Caturelli, Miguel. Universidad Nacional de Córdoba. Facultad de Ciencias Exactas, Físicas y Naturales; Argentina.Fil: Strumia, Miriam. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas; Argentina

Comisión de Innovación, Transferencia y Vinculación Tecnológica Acta 1

1. Inicio de actividades. 2. Información general sobre reuniones y calendario tentativo. 3. Propuesta de actores de la comunidad universitaria para conformación de la comisión.Fil: Arias, Fulvio. Universidad Nacional de Córdoba. Facultad de Ciencias Exactas, Físicas y Naturales; Argentina.Fil: Berti, Agustín. Universidad Nacional de Córdoba. Facultad de Artes; Argentina.Fil: Colombo, Andrés. Universidad Nacional de Córdoba. Secretaría de Ciencia y Tecnología; Argentina.Fil: Dalmagro, María Cristina. Universidad Nacional de Córdoba. Facultad de Lenguas; Argentina.Fil: Francisca, Franco Matías. Universidad Nacional de Córdoba. Secretaría de Ciencia y Tecnología; Argentina.Fil: Giacomelli, Carla. Universidad Nacional de Córdoba. Secretaría de Ciencia y Tecnología; Argentina.Fil: Guzmán, Patricia Elizabeth. Universidad Nacional de Córdoba. Secretaría de Ciencia y Tecnología; Argentina.Fil: Matta, Andrés. Universidad Nacional de Córdoba. Facultad de Ciencias Económicas; Argentina.Fil: Pury, Pedro Ángel. Universidad Nacional de Córdoba. Facultad de Matemática, Astronomía, Física y Computación; Argentina.Fil: Ruiz Caturelli, Miguel. Universidad Nacional de Córdoba. Facultad de Ciencias Exactas, Físicas y Naturales; Argentina.Fil: Strumia, Miriam. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas; Argentina

Observation of Geo-Neutrinos

Geo-neutrinos, electron anti-neutrinos produced in beta decays of naturally occurring radioactive isotopes in the Earth, are a unique direct probe of our planet's interior. We report the first observation at more than 3$\sigma$ C.L. of geo-neutrinos, performed with the Borexino detector at Laboratori Nazionali del Gran Sasso. Anti-neutrinos are detected through the neutron inverse beta decay reaction. With a 252.6 ton-yr fiducial exposure after all selection cuts, we detected 9.9^{+4.1}_{-3.4}(^{+14.6}_{-8.2}) geo-neutrino events, with errors corresponding to a 68.3%(99.73%) C.L. From the $\ln{\cal{L}}$ profile, the statistical significance of the Borexino geo-neutrino observation corresponds to a 99.997% C.L. Our measurement of the geo-neutrinos rate is 3.9^{+1.6}_{-1.3}(^{+5.8}_{-3.2}) events/(100ton-yr). This measurement rejects the hypothesis of an active geo-reactor in the Earth's core with a power above 3 TW at 95% C.L. The observed prompt positron spectrum above 2.6 MeV is compatible with that expected from european nuclear reactors (mean base line of approximately 1000 km). Our measurement of reactor anti-neutrinos excludes the non-oscillation hypothesis at 99.60% C.L.Comment: 8 pages, 4 figures, 3 table

Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry. Could survival differ in a high-volume center?

BACKGROUND: As yet, no population-based prospective studies have been conducted to investigate the incidence and clinical outcome of glioblastoma (GBM) or the diffusion and impact of the current standard therapeutic approach in newly diagnosed patients younger than aged 70 years. METHODS: Data on all new cases of primary brain tumors observed from January 1, 2009, to December 31, 2010, in adults residing within the Emilia-Romagna region were recorded in a prospective registry in the Project of Emilia Romagna on Neuro-Oncology (PERNO). Based on the data from this registry, a prospective evaluation was made of the treatment efficacy and outcome in GBM patients. RESULTS: Two hundred sixty-seven GBM patients (median age, 64 y; range, 29-84 y) were enrolled. The median overall survival (OS) was 10.7 months (95% CI, 9.2-12.4). The 139 patients 64aged 70 years who were given standard temozolomide treatment concomitant with and adjuvant to radiotherapy had a median OS of 16.4 months (95% CI, 14.0-18.5). With multivariate analysis, OS correlated significantly with KPS (HR = 0.458; 95% CI, 0.248-0.847; P = .0127), MGMT methylation status (HR = 0.612; 95% CI, 0.388-0.966; P = .0350), and treatment received in a high versus low-volume center (HR = 0.56; 95% CI, 0.328-0.986; P = .0446). CONCLUSIONS: The median OS following standard temozolomide treatment concurrent with and adjuvant to radiotherapy given to (72.8% of) patients aged 6470 years is consistent with findings reported from randomized phase III trials. The volume and expertise of the treatment center should be further investigated as a prognostic factor

COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context

Background and objectives: It is unclear how multiple sclerosis (MS) affects the severity of COVID-19. The aim of this study is to compare COVID-19-related outcomes collected in an Italian cohort of patients with MS with the outcomes expected in the age- and sex-matched Italian population. Methods: Hospitalization, intensive care unit (ICU) admission, and death after COVID-19 diagnosis of 1,362 patients with MS were compared with the age- and sex-matched Italian population in a retrospective observational case-cohort study with population-based control. The observed vs the expected events were compared in the whole MS cohort and in different subgroups (higher risk: Expanded Disability Status Scale [EDSS] score > 3 or at least 1 comorbidity, lower risk: EDSS score ≤ 3 and no comorbidities) by the χ2 test, and the risk excess was quantified by risk ratios (RRs). Results: The risk of severe events was about twice the risk in the age- and sex-matched Italian population: RR = 2.12 for hospitalization (p < 0.001), RR = 2.19 for ICU admission (p < 0.001), and RR = 2.43 for death (p < 0.001). The excess of risk was confined to the higher-risk group (n = 553). In lower-risk patients (n = 809), the rate of events was close to that of the Italian age- and sex-matched population (RR = 1.12 for hospitalization, RR = 1.52 for ICU admission, and RR = 1.19 for death). In the lower-risk group, an increased hospitalization risk was detected in patients on anti-CD20 (RR = 3.03, p = 0.005), whereas a decrease was detected in patients on interferon (0 observed vs 4 expected events, p = 0.04). Discussion: Overall, the MS cohort had a risk of severe events that is twice the risk than the age- and sex-matched Italian population. This excess of risk is mainly explained by the EDSS score and comorbidities, whereas a residual increase of hospitalization risk was observed in patients on anti-CD20 therapies and a decrease in people on interferon